期刊文献+

MS-275对急性肝衰竭小鼠肝脏的保护作用 被引量:4

Protective effect of histone deacetylase inhibitor MS-275 on acute liver failure induced by D-galactosamine and lipopolysaccharide in mice
原文传递
导出
摘要 目的:观察组蛋白去乙酰化酶抑制剂MS-275对急性肝衰竭( ALF)小鼠肝脏的保护作用及对NF-κB信号通路的影响。方法选取SPF级C57 BL/6雄性小鼠30只,并随机分为健康对照组、ALF模型组和MS-275治疗组,每组10只。 ALF模型组和MS-275治疗组小鼠采用D-氨基半乳糖以及脂多糖( LPS)联合诱导小鼠ALF模型,其中MS-275治疗组小鼠在制备ALF模型前2 h腹腔注射MS-275。24 h后观察检测各组小组血清丙氨酸转氨酶( ALT)、天冬氨酸转氨酶( AST)、总胆红素(TBil)、肿瘤坏死因子(TNF)-α、干扰素(IFN)γ、白介素(IL)-1β、高迁移率族蛋白1(HMGB1)水平,取肝组织做HE染色观察肝组织结构并检测肝组织HDAC1、HDAC3、P65蛋白表达及乙酰化组蛋白、乙酰化、磷酸化P65蛋白的表达。采用t检验比较组间上述指标的差异。结果 HE染色结果显示,与ALF模型组相比,MS-275治疗组小鼠肝细胞损害程度明显降低,炎症细胞浸润减少。与ALF模型组相比,MS-275治疗组小鼠血清中 ALT、AST 和 TBil 水平明显降低( t =-22.215、-11.914和-12.160,P值均<0.05),但仍高于健康对照组(t =14.852、11.692和8.333,P值均<0.05);MS-275治疗组小鼠血清TNF-α、IFNγ、IL-1β、HMGB1表达水平也明显降低( t=-7.926、-3.427、-2.475和-5.920,P值均<0.05),但仍高于健康对照组,其中TNF-α和IFNγ水平与健康对照组比较,差异有统计学意义(t=5.541和5.514,P值均<0.05);MS-275治疗组小鼠肝组织中HDAC1和HDAC3蛋白表达明显下降(t=-3.676和-10.576,P值均<0.05),肝组织中乙酰化H3、H4和P65蛋白表达明显增加(t=3.976、5.559和4.588,P值均<0.05)。免疫组化结果提示,MS-275治疗组小鼠肝组织中P65表达总数及入核率均低于ALF模型组。结论 MS-275对ALF小鼠肝脏有保护作用,可能与非� Objective To investigate the effect of MS-275, an histone deacetylase ( HDAC ) inhibitor, on acute liver failure ( ALF ) induced by D-galactosamine and lipopolysaccharide in mice. Methods Thirty specific pathogen free (SPF) C57BL/6 male mice were randomly and equally divided into control, ALF model and MS-275 groups. ALF model was induced by D-galactosamine ( D-Gal ) and lipopolysaccharide (LPS), and the mice in MS-275 group received MS-275 (1 mg/kg) at 2 h before the induction of ALF.Serum and liver samples of mice were obtained at 24 h after ALF induction.The serum levels of ALT, AST, TBil and tumor necrosis factor-alpha ( TNF-α) , interferon γ( IFNγ) , interleukin ( IL )-1β, high mobility group box 1 ( HMGB1 ) were tested by biochemical methods or ELISA kit, respectively.The expression of HDAC1, HDAC3, acetylation of histone H3, H4, P65, acetylation and phosphorylation of P65 in liver were detected by Western blotting.The changes of histology in liver was detected by HE staining, and the translocation of P65 in liver was detected by immunohistochemistry. Comparison of variables among the groups was performed using t test.Results MS-275 inhibited the infiltration of inflammatory cells and improved the pathological changes of liver tissue.Compared with ALF group, serum ALT, AST, TBil levels were decreased in MS-275 group ( t =-22.215, -11.914 and-12.160, all P〈0.05), but still higher than those in the control group (t=14.852, 11.692 and 8.333, all P〈0.05); serum TNF-α, IFNγ, IL-1β, HMGB1 levels were also significantly decreased in MS-275 group (t=-7.926, -3.427, -2.475 and -5.920, all P〈0.05), but TNF-αand IFNγwere still higher than those in the control group (t=5.541 and 5.514, all P〈0.05).Compared with control group, the expression of class I HDAC in liver tissue was significantly decreased in MS-275 group ( t=-3.676 and-10.576, P〈0.05), while the expressions of acetylation of histone H3, H4 and P65 were significantly inc
出处 《中华临床感染病杂志》 2016年第4期349-354,共6页 Chinese Journal of Clinical Infectious Diseases
基金 国家自然科学基金(81371789)
关键词 组蛋白去乙酰化酶抑制剂 肝功能衰竭 急性 MS-275 P65 MS-275 P65 Histone deacetylase inhibitors Liver failure,acute
  • 相关文献

参考文献1

二级参考文献10

  • 1Ninomiya-Tsuji J,Kishimoto K,Hiyama A,Inoue J,Cao Z,Matsumoto K.The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway[].Nature.1999 被引量:1
  • 2Baeuerle PA,Baltimore D.A 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB[].Genes and Development.1989 被引量:1
  • 3Carty M,Goodbody R,Schroder M,Stack J,Moynagh PN,Bowie AG.The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling[].Nature Immunology.2006 被引量:1
  • 4Qin J,Jiang Z,Qian Y,Casanova JL,Li X.IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness[].Journal of Biological Chemistry.2004 被引量:1
  • 5Kobayashi K,Hernandez LD,Galan JE,Janeway CA Jr,Medzhitov R,Flavell RA.IRAK-M is a negative regulator of Toll-like receptor signaling[].Cell.2002 被引量:1
  • 6Burns K,Janssens S,Brissoni B,Olivos N,Beyaert R,Tschopp J.Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4[].The Journal of Experimental Medicine.2003 被引量:1
  • 7Bohuslav J,Chen LF,Kwon H,Mu Y,Greene WC.p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1[].Journal of Biological Chemistry.2004 被引量:1
  • 8Jiang Z,Mak TW,Sen G,Li X.Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β[].Proceedings of the National Academy of Sciences of the United States of America.2004 被引量:1
  • 9Vidal S,Khush RS,Leulier F,Tzou P,Nakamura M,Lemaitre B.Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-κB-dependent innate immune responses[].Genes and Development.2001 被引量:1
  • 10Kawai T,Takeuchi O,Fujita T, et al.Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes[].J Immunol.2001 被引量:1

共引文献64

同被引文献12

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部